Gut-friendly psychobiotics could brighten moods and fight depression

Patients with high-risk relapsed/refractory follicular lymphoma experienced statistically significant and clinically meaningful responses when treated with lisocabtagene maraleucel (liso-cel; Breyanzi) as second-line therapy, according to

Op­tum Rx is mov­ing in­to the biosim­i­lar busi­ness with a com­pa­ny it’s call­ing Nu­vaila, and it’s start­ing out with biosim­i­lars to Ab­b­Vie’s block­buster rheuma­toid arthri­tis